Dr. Said Daneshmand
Dr. Said Daneshmand is an internationally recognized fertility specialist with extensive experience in providing third-party reproductive services.
Dr. Daneshmand serves on the board of several surrogacy advocacy groups. He has collaborated to develop in vitro fertilization (IVF) protocols to improve pregnancy rates, including PTEC (post-thaw extended culture), which is one of the most successful IVF regimens currently available. These groundbreaking findings were published in the internationally respected medical journal, Fertility and Sterility, where Dr. Daneshmand also served as a reviewer.
Dr. Daneshmand completed his fellowship and residency at UCLA. He is specialty board certified in Obstetrics and Gynecology and sub specialty board certified in Reproductive Endocrinology.
Among his achievements, Dr. Daneshmand is the recipient of numerous awards including the Eileen Pike Medical School Valedictorian Award and the PCRS Fellowship and Practicing Physician Research Award. He has served as the President of the Alpha Omega Alpha Honor Society (Iota Chapter) and is a member of the Decherney Society, the American Society for Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embryology (ESHRE). Dr. Daneshmand speaks French, Spanish and Farsi.
”My patients’ deep desire to become parents is the singular driving force in my career. I am committed to traveling this, at times arduous road with them while holding their hands through their unique journey to parenthood. With steadfast dedication, we forge ahead together to overcome the challenges in attaining this foremost goal to achieve success.” – Dr. Said Daneshmand
Dr. Daneshmand has an expertise in complex IVF cases, and his research has featured work on endometrial receptivity as a way to maximize the probability of success during IVF. He is internationally recognized for his expertise in egg donation and surrogacy, and is one of the main providers on third-party care in the United States, with patients traveling from more than 40 countries in 2018 alone. Dr. Daneshmand has presented his research all over the world, including many presentations to leading IVF experts in China. He is known for developing and implementing cutting-edge technologies, including NGS (next generation sequencing), the latest and most precise technique for assessing embryonic genetic health.